MID1IP1-AS1

Across TCGA pan-cancer cohorts, MID1IP1-AS1 RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated MID1IP1-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MID1IP1-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MID1IP1-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and ACC show a favorable association.

KIRC, ACC, and LUAD are the cancer types where MID1IP1-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	II,III,IV	0.713	0.291	<.001	41	view →
ACC	DFS	Median	III,IV	0.826	0.290	.001	40	view →
LUAD	DFS	Tertile	IV	0.840	0.175	.006	17	view →
STAD	DFS	Quartile	All	0.616	0.378	.004	12	view →
THCA	OS	Quartile	All	0.982	1.000	.013	12	view →
KICH	OS	Median	All	0.759	0.971	.009	11	view →
SKCM	OS	Quartile	IV	0.850	0.490	.020	11	view →
LUSC	OS	Tertile	All	0.817	0.714	.005	11	view →
READ	OS	Tertile	III,IV	0.855	0.518	.024	10	view →
COAD	OS	Quartile	All	0.866	0.676	.017	7	view →
ESCA	DFS	Tertile	IV	0.216	0.704	.024	6	view →
UCS	OS	Median	IV	0.693	0.262	.047	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 23 lineages.

MID1IP1-AS1–KIRC (DFS)

Open the KIRC breakdown →